
Automata helps life sciences labs automate experiments to increase throughput, reduce manual steps, and improve data quality. It delivers the LINQ platform, a modular combination of lab robotics hardware and cloud-based, AI-ready workflow management software that lets scientists program experiments rather than individual robots. The platform is open and configurable, designed for integration with existing lab instruments, LIMS, and data systems, and targets research, diagnostic, and biotech customers. Automata operates as a B2B lab automation provider working with research institutions and industry labs to modernize laboratory operations.

Automata helps life sciences labs automate experiments to increase throughput, reduce manual steps, and improve data quality. It delivers the LINQ platform, a modular combination of lab robotics hardware and cloud-based, AI-ready workflow management software that lets scientists program experiments rather than individual robots. The platform is open and configurable, designed for integration with existing lab instruments, LIMS, and data systems, and targets research, diagnostic, and biotech customers. Automata operates as a B2B lab automation provider working with research institutions and industry labs to modernize laboratory operations.
Company: AUTOMATA — lab automation platform maker (LINQ)
Founded: 2015
Founders: Mostafa ElSayed, Suryansh Chandra
Headcount (approx.): 195
Known total funding: ≈ $99.8M (USD)
| Company |
|---|
Automating wet‑lab processes to improve efficiency, throughput and data quality in life sciences labs.
2015
IT Services and IT Consulting
$7.4M
Series A to commercialize desktop robotic arm 'Eva'.
US$50M
Round to scale lab‑automation hardware and software.
$40M
Equity financing announced in October 2023 to expand LINQ platform and go‑to‑market.
$45M
Series C announced to scale AI‑ready lab automation; participation from Danaher Ventures, Entrepreneurs First, Octopus Ventures and others.
“A.P. Moller Holding; ABB Ventures; Dimension (lead); Octopus Ventures; Entrepreneurs First; Danaher Ventures; Hummingbird Ventures; Isomer Capital; LocalGlobe; Firstminute Capital; Possible Ventures; Blue Wire Capital; HCVC; IQT; Aldea Ventures; Ahmed Medhat”
Level***: 5/6 depending on experience***
Salary band***: £110,000 - £150,000***
Bonus***:*** 10% performance-based, discretionary
Location***:*** Hybrid - 3 days per week onsite at our London office (Angel, Islington)
At Automata, we're on a mission to transform how scientists work by making automation accessible to every lab in the world. We believe that by giving labs the power to automate, we can unlock discoveries that will shape the future of life sciences—from diagnostics and drug discovery to synthetic biology.
But we’re more than just a company disrupting the industry—we're a team of innovators, problem-solvers, and creators passionate about empowering scientists. Our LINQ platform combines hardware and software to streamline workflows, making lab automation fast, flexible, and affordable. This means our customers can focus on groundbreaking research, while we take care of the rest.
Why Work at Automata?
We are looking for a Principal Product Manager to take a leading role in shaping Automata’s platform and execution. This is a senior, hands-on role for a product leader who thrives in fast-moving environments, takes full ownership, and consistently turns complex problems into shipped, high-impact products.
You will lead some of Automata’s most technically and strategically important areas — including workflow orchestration, scheduling, and device integration — helping transform our platform from powerful building blocks into cohesive, customer-ready solutions.
Vitality Health Insurance
Eye Care
Salary Sacrifice - EV
Salary Sacrifice - Bike & Tech
Spill & Employee Assistance Programme
Additional Leave
Pension Scheme
Group Life & Critical Illness cover
We are an equal-opportunity employer. We celebrate diversity and are committed to creating an inclusive environment for all employees. Discrimination of any kind based on race, colour, religion, gender, sexual orientation, gender identity or expression, national origin, age, genetic information, disability, or veteran status is strictly prohibited.